Intravaginal use of clindamycin phosphate in therapy of bacterial vaginosis: peculiarities of pharmacokinetics depending on the level of hydrogen sulfide in the organism (literature review)

Abstract

Annotation. The article provides an overview of modern literature data on the problems of bacterial vaginosis, its therapy with clindamycin, the pharmacokinetics of this pharmacological drug, and the potential effect of the background level of hydrogen sulfide in the body on the pharmacokinetics of drugs. From PubMed, ScienceDirect, UpToDate databases, 50 sources were selected that met the conditions of the query: the latest publications (for the last 5 years), or the latest publications on this issue (regardless of age). The wide and diverse influence of endogenous hydrogen sulfide on the course of biochemical and physiological processes in the body prompts the study of its potential modulating effect on the pharmacological properties of drugs. A preclinical study of the pharmacokinetics and pharmacodynamics of drugs (in particular, clindamycin) will further optimize therapeutic regimens taking into account the level of hydrogen sulfide in the body, as well as create the preconditions for the development of new effective pharmaceutical compositions of antibiotics and hydrogen sulfide donors.